These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38300956)

  • 1. Using a mobile nanopore sequencing lab for end-to-end genomic surveillance of Plasmodium falciparum: A feasibility study.
    Holzschuh A; Lerch A; Fakih BS; Aliy SM; Ali MH; Ali MA; Bruzzese DJ; Yukich J; Hetzel MW; Koepfli C
    PLOS Glob Public Health; 2024; 4(2):e0002743. PubMed ID: 38300956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria Molecular Surveillance in the Peruvian Amazon with a Novel Highly Multiplexed Plasmodium falciparum AmpliSeq Assay.
    Kattenberg JH; Fernandez-Miñope C; van Dijk NJ; Llacsahuanga Allcca L; Guetens P; Valdivia HO; Van Geertruyden JP; Rovira-Vallbona E; Monsieurs P; Delgado-Ratto C; Gamboa D; Rosanas-Urgell A
    Microbiol Spectr; 2023 Feb; 11(2):e0096022. PubMed ID: 36840586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance and vaccine target surveillance of Plasmodium falciparum using nanopore sequencing in Ghana.
    Girgis ST; Adika E; Nenyewodey FE; Senoo Jnr DK; Ngoi JM; Bandoh K; Lorenz O; van de Steeg G; Harrott AJR; Nsoh S; Judge K; Pearson RD; Almagro-Garcia J; Saiid S; Atampah S; Amoako EK; Morang'a CM; Asoala V; Adjei ES; Burden W; Roberts-Sengier W; Drury E; Pierce ML; Gonçalves S; Awandare GA; Kwiatkowski DP; Amenga-Etego LN; Hamilton WL
    Nat Microbiol; 2023 Dec; 8(12):2365-2377. PubMed ID: 37996707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing.
    de Cesare M; Mwenda M; Jeffreys AE; Chirwa J; Drakeley C; Schneider K; Mambwe B; Glanz K; Ntalla C; Carrasquilla M; Portugal S; Verity RJ; Bailey JA; Ghinai I; Busby GB; Hamainza B; Hawela M; Bridges DJ; Hendry JA
    Nat Commun; 2024 Feb; 15(1):1413. PubMed ID: 38360754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive, Highly Multiplexed Sequencing of Microhaplotypes From the Plasmodium falciparum Heterozygome.
    Tessema SK; Hathaway NJ; Teyssier NB; Murphy M; Chen A; Aydemir O; Duarte EM; Simone W; Colborn J; Saute F; Crawford E; Aide P; Bailey JA; Greenhouse B
    J Infect Dis; 2022 Apr; 225(7):1227-1237. PubMed ID: 32840625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study.
    Beshir KB; Muwanguzi J; Nader J; Mansukhani R; Traore A; Gamougam K; Ceesay S; Bazie T; Kolie F; Lamine MM; Cairns M; Snell P; Scott S; Diallo A; Merle CS; NDiaye JL; Razafindralambo L; Moroso D; Ouedraogo JB; Zongo I; Kessely H; Doumagoum D; Bojang K; Ceesay S; Loua K; Maiga H; Dicko A; Sagara I; Laminou IM; Ogboi SJ; Eloike T; Milligan P; Sutherland CJ
    Lancet Infect Dis; 2023 Mar; 23(3):361-370. PubMed ID: 36328000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution melting: a useful field-deployable method to measure dhfr and dhps drug resistance in both highly and lowly endemic Plasmodium populations.
    Ndiaye YD; Diédhiou CK; Bei AK; Dieye B; Mbaye A; Mze NP; Daniels RF; Ndiaye IM; Déme AB; Gaye A; Sy M; Ndiaye T; Badiane AS; Ndiaye M; Premji Z; Wirth DF; Mboup S; Krogstad D; Volkman SK; Ahouidi AD; Ndiaye D
    Malar J; 2017 Apr; 16(1):153. PubMed ID: 28420422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria.
    Quan H; Igbasi U; Oyibo W; Omilabu S; Chen SB; Shen HM; Okolie C; Chen JH; Zhou XN
    Infect Dis Poverty; 2020 Jul; 9(1):91. PubMed ID: 32653033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention.
    van Lenthe M; van der Meulen R; Lassovski M; Ouabo A; Bakula E; Badio C; Cibenda D; Okell L; Piriou E; Grignard L; Lanke K; Rao B; Bousema T; Roper C
    Malar J; 2019 Dec; 18(1):430. PubMed ID: 31852480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism analysis of drug resistance markers in Plasmodium falciparum isolates from Benin.
    L'Episcopia M; Doderer-Lang C; Perrotti E; Priuli GB; Cavallari S; Guidetti C; Bernieri F; Menard D; Severini C
    Acta Trop; 2023 Sep; 245():106975. PubMed ID: 37348801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a parasite-density based pooled targeted amplicon deep sequencing (TADS) method for molecular surveillance of Plasmodium falciparum drug resistance genes in Haiti.
    Louha S; Herman C; Gupta M; Patel D; Kelley J; Oh JM; Guru J; Lemoine JF; Chang MA; Venkatachalam U; Rogier E; Talundzic E
    PLoS One; 2022; 17(1):e0262616. PubMed ID: 35030215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel highly-multiplexed AmpliSeq targeted assay for
    Kattenberg JH; Nguyen HV; Nguyen HL; Sauve E; Nguyen NTH; Chopo-Pizarro A; Trimarsanto H; Monsieurs P; Guetens P; Nguyen XX; Esbroeck MV; Auburn S; Nguyen BTH; Rosanas-Urgell A
    Front Cell Infect Microbiol; 2022; 12():953187. PubMed ID: 36034708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid diagnostic tests for molecular surveillance of Plasmodium falciparum malaria -assessment of DNA extraction methods and field applicability.
    Morris U; Aydin-Schmidt B; Shakely D; Mårtensson A; Jörnhagen L; Ali AS; Msellem MI; Petzold M; Gil JP; Ferreira PE; Björkman A
    Malar J; 2013 Mar; 12():106. PubMed ID: 23510231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
    Raman J; Kagoro FM; Mabuza A; Malatje G; Reid A; Frean J; Barnes KI
    Malar J; 2019 Aug; 18(1):280. PubMed ID: 31438951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of Plasmodium falciparum using antigenic polymorphic markers and to study anti-malarial drug resistance markers in malaria endemic areas of Bangladesh.
    Akter J; Thriemer K; Khan WA; Sullivan DJ; Noedl H; Haque R
    Malar J; 2012 Nov; 11():386. PubMed ID: 23173674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections.
    Zainabadi K; Adams M; Han ZY; Lwin HW; Han KT; Ouattara A; Thura S; Plowe CV; Nyunt MM
    Malar J; 2017 Sep; 16(1):377. PubMed ID: 28923054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proof of concept: used malaria rapid diagnostic tests applied for parallel sequencing for surveillance of molecular markers of anti-malarial resistance in Bissau, Guinea-Bissau during 2014-2017.
    Nag S; Ursing J; Rodrigues A; Crespo M; Krogsgaard C; Lund O; Aarestrup FM; Alifrangis M; Kofoed PE
    Malar J; 2019 Jul; 18(1):252. PubMed ID: 31349834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide spatiotemporal drug resistance genetic profiling from over three decades in Indian Plasmodium falciparum and Plasmodium vivax isolates.
    Kojom Foko LP; Narang G; Jakhan J; Tamang S; Moun A; Singh V
    Malar J; 2023 Aug; 22(1):236. PubMed ID: 37582796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019.
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Kabututu PZ; Akilimali PZ; Situakibanza HNT; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
    BMC Infect Dis; 2022 Feb; 22(1):145. PubMed ID: 35144535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.